GAO audit outlines CMMI’s limited scale-ups, draws new criticism
A Government Accountability Office audit of the Center for Medicare and Medicaid Innovation Center’s historical spending and the outcomes of...
Policy Tracker: Exceptions to State Abortion Bans and Early Gestational Limits
Abortion is currently banned in 13 states and 7 states have early gestational limits between 6 weeks and 12 weeks...
Hospitals want Congress to refine long-term care hospital pay
Hospital associations have laid out their policy wish list for Congress regarding long-term care hospitals (LTCH), calling for refinements to...
How to calculate patient responsibility in medical billing
At A Glance Calculating patient responsibility in medical billing requires accurate, real-time data on coverage, benefits and payer rules. This...
Public Opinion on Prescription Drugs and Their Prices
Many Americans face significant challenges affording their medications, including adults who take more medications or have lower incomes. KFF polling...
No More Injections? FDA Clears First Daily Pill for Moderate to Severe Psoriasis
For millions of people living with moderate-to-severe plaque psoriasis, the “gold standard” of treatment has long come with a literal...
Providence trims 2025 operating loss to $132M, notches Q4 gain
Providence made another substantial dent in its annual operating losses as it pared back non-core service, reduced its headcount and...
One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024
Editorial Note: This brief updates a previous analysis with more recent data, an evaluation of increases in concentration over time,...
Everyday PCOS Struggles, Finally Explained with TES
When you’re told you have polycystic ovary syndrome (PCOS), it sounds like a clear diagnosis. But living with PCOS is...
3 more drugs in the pipeline Optum says payers should watch
A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and...
